Results 231 to 240 of about 351,618 (311)
Antenatal Corticosteroids and Bronchopulmonary Dysplasia in Very Preterm Infants.
Gao L +4 more
europepmc +1 more source
Changes in the contributions of risk factors to under-five mortality in low- and lower-middle-income countries (1997-2022): an analysis of Demographic and Health Survey data. [PDF]
Kefale B +4 more
europepmc +1 more source
Objective We assessed the effectiveness of PrismRA to improve clinical outcomes among patients with rheumatoid arthritis (RA) initiating treatment with a biologic or targeted synthetic disease‐modifying antirheumatic drug (b/tsDMARD). Methods PrismRA incorporated 19 gene expression features and four clinical features to assess a patient's likelihood of
Fenglong Xie +3 more
wiley +1 more source
MRI patterns and clinical outcomes in cerebral palsy: insights from a large MRICS-based cohort. [PDF]
Yuan J +8 more
europepmc +1 more source
Epidemiology of early childhood weight change and concurrent undernutrition among African children: A sub-continental observational analysis. [PDF]
Adanikin A +3 more
europepmc +1 more source
Objective Frailty occurs prematurely in rheumatoid arthritis (RA) and is associated with poor health outcomes. We compared the performance of four frailty instruments, including a pragmatic alternative measure using chair sit‐to‐stand (STS), and evaluated their abilities to predict poor health outcomes.
Kylie E. Riggles +14 more
wiley +1 more source
Objective This study aimed to investigate potential moderators influencing the effects of manual therapy and exercise therapy on pain and functional outcomes in individuals with knee and/or hip osteoarthritis, using data from the MOA trial. This is a secondary analysis of data from the MOA trial that compares the clinical effectiveness of manual ...
Daniel Cury Ribeiro +2 more
wiley +1 more source
Between continuities and innovations: what CSP has in store for 2026. [PDF]
Alves LC, Carvalho MS, Lima LD.
europepmc +1 more source
Objective Clinical response to mycophenolic acid (MPA) is highly heterogeneous; thus, therapeutic drug level monitoring (TDM) may help improve treatment efficacy. This systematic review and meta‐analysis examined therapeutic ranges for MPA levels associated with better outcomes and safety in patients with systemic lupus erythematosus (SLE ...
Zahraa Qamhieh +5 more
wiley +1 more source

